BackNuvation Bio Overview

Nuvation Bio Long Term Debt

Nuvation Bio's long-term debt is $240M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$244.53M
26.60% YoYΔ $51.38M vs prior year quarter

Peer trimmed avg / median

Loading

Nuvation Bio Long Term Debt History

Loading

Nuvation Bio vs. peers: Long Term Debt Comparison

Loading

Nuvation Bio Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Nuvation Bio (NUVB) FAQ

As of the most recent data (June 2026), NUVB shows a long-term debt of $240M. That compares with $190M in the prior-year period — up 26.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NUVB's long-term debt is now $240M (was $190M) — a 26.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Nuvation Bio is outperforming or lagging.

Tracking NUVB's long-term debt over time shows whether Nuvation Bio is scaling, shrinking, or reshaping that part of the business. The current reading is $240M That compares with $190M in the prior-year period — up 26.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Nuvation Bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $240M) with ownership activity and broader fundamentals.

Nuvation Bio's long-term debt is $240M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.